Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of drug prescribing before and during the COVID‐19 pandemic: A cross‐national European study
Iva Selke Krulichová, Gisbert Selke, Marion Bennie, et al.
Pharmacoepidemiology and Drug Safety (2022) Vol. 31, Iss. 10, pp. 1046-1055
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Costs are a major driver of antibacterial drug prescriptions in Germany: market analysis from 1985 to 2022
Lilly Josephine Bindel, Roland Seifert
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Open Access | Times Cited: 7
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Mikael Tiger, Giulio Castelpietra, Rikke Wesselhöeft, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals
Amanj Kurdi, Najla Al Mutairi, Kirmanj Baker, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-12
Open Access | Times Cited: 5
Psychotropic drug prescribing before and during the COVID-19 pandemic among people with depressive and anxiety disorders: a multinational network study
Hao Luo, Yi Chai, Sijia Li, et al.
The Lancet Psychiatry (2024) Vol. 11, Iss. 10, pp. 807-817
Closed Access | Times Cited: 5
Initiation of Anticoagulants During the COVID‐19 Pandemic in Sweden: An Interrupted Time Series Analysis
Per‐Jostein Samuelsen, Björn Wettermark, Fredrik Nyberg, et al.
Basic & Clinical Pharmacology & Toxicology (2025) Vol. 136, Iss. 2
Open Access
Evaluating the utilisation patterns of pharmacological therapy in COVID-19 patients: an ecological study in Italy
Maria Lucia Marino, Aurora Di Filippo, Graziano Onder, et al.
BMJ Public Health (2025) Vol. 3, Iss. 1, pp. e001767-e001767
Open Access
The environmental impact of pharmaceuticals in Italy: Integrating healthcare and eco‐toxicological data to assess and potentially mitigate their diffusion to water supplies
Valentina Giunchi, Michele Fusaroli, Elkanah Linder, et al.
British Journal of Clinical Pharmacology (2023) Vol. 89, Iss. 7, pp. 2020-2027
Open Access | Times Cited: 9
Treatment seeking and antibiotic use for urinary tract infection symptoms in the time of COVID-19 in Tanzania and Uganda
Emmanuel Olamijuwon, Katherine Keenan, Martha F. Mushi, et al.
Journal of Global Health (2024) Vol. 14
Open Access | Times Cited: 2
Effects of the COVID-19 pandemic on healthcare utilization among older adults with cardiovascular diseases and multimorbidity in Indonesia: an interrupted time-series analysis
Royasia Viki Ramadani, Mikael Svensson, Sven Hassler, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Trends and regional differences in antidiabetic medication use: a nationwide retrospective observational study
Márta Csatordai, Ria Benkő, Mária Matúz, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Prescription trends of antiseizure medications before and during the COVID-19 pandemic
Alekhya Lavu, Donica Janzen, Laila Aboulatta, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Trends in medication use at the onset of and during the COVID‐19 pandemic in the Republic of Ireland: An interrupted time series study
Molly Mattsson, Jung A. Hong, John Scott Frazer, et al.
Basic & Clinical Pharmacology & Toxicology (2023) Vol. 134, Iss. 2, pp. 231-240
Open Access | Times Cited: 3
Trends in Prescription Chronic Pain Medication Use before and during the First Wave of the COVID-19 Pandemic in Québec, Canada: An Interrupted Time Series Analysis
Gwenaëlle De Clifford‐Faugère, Hermine Lore Nguena Nguefack, Manon Choinière, et al.
International Journal of Environmental Research and Public Health (2023) Vol. 20, Iss. 15, pp. 6493-6493
Open Access | Times Cited: 2
Diagnosis-linked antibiotic prescribing quality indicators: demonstrating feasibility using practice-based routine primary care data, reliability, validity and their potential in antimicrobial stewardship
Sharon E J D van den Eijnde, Paul D. van der Linden, Alike W. van der Velden
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 4, pp. 767-773
Closed Access
Influence of practice location on prescribing, diabetes care, and colorectal cancer screening among Czech general practitioners during the COVID-19 pandemic
Jan Bělobrádek, Luděk Šídlo, Tom Philipp
Epidemiology and Health (2024), pp. e2024033-e2024033
Open Access
Bolnišnične obravnave zaradi bolezni mišično-skeletnega sistema in vezivnega tkiva v letu 2022 v Sloveniji
Marjetka Jelenc, Sabina Sedlak, Sandra Simonović
(2024), pp. 409-418
Open Access
Impact of the COVID-19 pandemic on the utilization and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time series analysis
Hayam Al Balushi, Amanj Kurdi, Najla Almutairi, et al.
Expert Review of Anti-infective Therapy (2024), pp. 1-11
Open Access
Trends in medicine utilisation in public and private healthcare facilities before and during COVID-19: a nationwide analysis of medicine procurement and sales data, 2018–2022
Norazida Ab Rahman, Ee Vien Low, Audrey Huili Lim, et al.
Journal of Pharmaceutical Policy and Practice (2024) Vol. 17, Iss. 1
Open Access
Noninterventional studies in the COVID-19 era: methodological considerations for study design and analysis
Anne M. Butler, Mehmet Burcu, Jennifer Christian, et al.
Journal of Clinical Epidemiology (2022) Vol. 153, pp. 91-101
Open Access | Times Cited: 3
Immediate and long-term effects of COVID-19 on antibiotic dispensing: increasing use of Watch antibiotics
Tanja Tomić, Martin Henman, Ivana Tadić, et al.
The Journal of Infection in Developing Countries (2024) Vol. 18, Iss. 04, pp. 504-512
Open Access
Bolnišnične obravnave zaradi bolezni mišično-skeletnega sistema in vezivnega tkiva v Sloveniji v obdobju 2016–2022
Sandra Simonović, Sabina Sedlak, Marjetka Jelenc
Revija za zdravstvene vede (2023) Vol. 10, Iss. 2, pp. 32-45
Open Access | Times Cited: 1
Arzneimittel-Kompass 2022
Helmut Schröder, Petra A. Thürmann, Carsten Telschow, et al.
Springer eBooks (2022)
Closed Access | Times Cited: 2
Der Arzneimittelmarkt 2021 im Überblick
Carsten Telschow, Melanie Schröder, Jana Bauckmann, et al.
Springer eBooks (2022), pp. 219-256
Closed Access | Times Cited: 1
Trends in estimated total retail dispensed prescriptions of purported COVID-19 treatments and preventions in Canada
Wajd Alkabbani, John‐Michael Gamble
Journal of Pharmaceutical Health Services Research (2023) Vol. 14, Iss. 2, pp. 99-102
Open Access
Page 1 - Next Page

Scroll to top